Clinical Trial Update: Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

View source ↗

Summary

This clinical trial is investigating middle meningeal artery embolization as a treatment for chronic subdural hematoma and is currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Snippet

Sponsor: Montefiore Medical Center | Conditions: Chronic Subdural Hematoma | Status: RECRUITING